Easy spread, with minimal cancellation or amendment risk.
Guest Pitch: LivePerson (LPSN)
Merger arbitrage: 18% upside (at $2.82/share)
Buying the Buyer, Not the Target
The parent will trade at a ridiculously low valuation once it takes its cash cow subsidiary private at a steal of a price.
Royalty Shell at 50% Discount to Asset Value
Strategic review is ongoing, messy accounting hides the actual profitability.
A Bid Is on the Table yet the Discount Is Still Wide
Comparable transactions and peer marks point to the bid landing above the current price.
Wide Spread and a Possible Bidding War
The offer was already raised once.
Spread Widened Sharply after Recent Price Drop
Same buyout, second entry point.
Potential Takeover with 40% Upside
The optionality on a sale looks close to free, in a business that has been quietly compounding.
A Wide Spread on a Deal That Looks Solid
While the offer is still non-binding, several factors suggest that the spread might be too wide.
Quick Pitch: Docebo (DCBO)
Odd-Lot Tender Offer: $140 upside (at $19.00)
Odd-Lot Tender Offer
Easy spread, with minimal cancellation or amendment risk.
Pending Buyout by a Controlling Shareholder
When one share class prices in a buyout and the other doesn’t.
Market Overreaction
65% potential upside on a rebound.
Waldencast (WALD) — Large Asset Sale — 25%+ Upside
Current Price: $1.50
Target Price: $1.80-$1.90
Potential Upside: 25%
Expected Timeline: Q3 2026
Quick Pitch: Continental Aerospace Technologies (0232:HK)
Liquidation: 10%+ Upside (at HK$0.39)
Quick Pitch: Aumann (AAG:DE)
Odd-lot Tender Offer: €190 Upside (at €14.60/share)
Quick Pitch: Optimum Communications (OPTU)
Odd-lot tender offer: $140 upside (at $1.08/share)
Yet Another Straightforward Merger Arb
With closing expected in 6 months, the IRR is compelling.
Quick Pitch: Zinnwald Lithium (ZNWD:L)
Merger Arbitrage: 18% Upside (at 8.75p/share)
Cheap Optionality in a Busted Biopharma
Massive discount to net cash, reputable management, and activist in place.
Quick Pitch: oOh!media Limited (OML:AX)
Bidding war: 30% Upside (at A$1.32-A$1.35)
DCC plc (DCC:L) — Higher Offer — 20%+ Upside
Current Price: £57.4
Target Price: £70.0
Potential Upside: 22%
Expected Timeline: one month
Cash-Rich Operating Business at No Cost
Ridiculous Privatization Attempt: 40-70% Bump Expected
A Big Haircut on the Interest Bill
Upcoming refinancing could lift FCF by 50%.
Quick Pitch: Blackline Safety (BLN:TO)
Free CVR: upside TBD (at $8.88)
Quick Pitch: Assertio Holdings (ASRT)
CVR: upside TBD (at $18.01)
A Clean “Free CVR” Setup
Closing is expected this quarter.
Quick Pitch: Enhabit (EHAB)
Higher offer: upside TBD (at $13.98)
Guest Pitch: Webjet Group (WJL:AX)
A bet on takeover talks resuming: 30%+ upside (at A$0.50)
Leggett & Platt (LEG) — Potential Buyout — 22%+ Upside
Current Price: $9.84
Target Price: $12+
Upside: 22%+
Expected Timeline: July-August 2026
Quick Pitch: Perfect (PERF)
Potential Buyout: 17.5% Upside (at $1.66)
Governance Shift Could Lead to a Takeover
The spread is wide, and the timeline is tight.
Distribution Solutions Group (DSGR) — Potential Buyout — 13%+ Upside
Current Price: $26.00
Offer Price: $29.50
Upside: 13%+
Expected Timeline: 2-5 months
Quick Pitch: Seer (SEER)
Activism: 35%+ Upside (at $1.83)
Sale & Large Capital Return
Capital return alone could exceed the market cap.
Tender Offer & Liquidation
40%-80% Potential Upside
Quick Pitch: Tripadvisor (TRIP)
Activism / Strategic review: 70% upside (at $10.06)
Guest Pitch: All for One Group SE (A1OS.DE)
Odd-lot Tender Offer: €150 Upside
Quick Pitch: Enviri (NVRI)
Large Asset Sale: 60% upside (at $19.04)
Potential Buyout With 40% Upside
If there is no deal, the downside is probably limited to only 10% to 15%.
Guest Pitch: uniQure (QURE)
FDA approval: 160% Upside (at $26.65)
Quick Pitch: Docebo (DCBO)
Odd-Lot Tender Offer: $80 upside (at $19.6)
Guest Pitch: Elme Communities (ELME)
Liquidation: 15% Upside (at $2.16)
A Clean and Low-Risk Liquidation Play
The wind-down should be completed this year.
Boring Business With an Intriguing Sale Catalyst
The market has largely ignored the recent developments, which makes the opportunity quite asymmetric.
Quick Pitch: ROK Resources (ROK:V)
Merger Arbitrage: 20%+ Upside (at C$0.20)
Angi (ANGI) — Turnaround — Upside TBD
Current Price: $12.5
Target Price: $20-$25
Upside: 50-100%
Expiration Date: Q3 2026
Quick Pitch: Lithium South Development Corporation (LIS:V)
Merger Arbitrage: 19% Upside (at C$0.425)
STAAR Surgical (STAA) — Expected Takeover — Upside 75%+
Current Price: $24.35
Target Price: $43+
Upside: 75%
Expected Timeline: 1-6 months
Guest Pitch: NCC Group (NCC:L)
Strategic Review and Sale Process – 20% Upside (at 144p)
Quick Pitch: Emeren Group (SOL)
Merger Arbitrage (at $1.73)
Focus List: 17 Actionable Special Sits
It has been a very productive year so far. We have published 73 new investment ideas on SSI, and while many have already played out, 42 write-ups are still marked as active.
Quick Pitch: Thunderbird Entertainment (TBRD:V)
Merger Arbitrage: 18% Upside (at C$1.55)
Quick Pitch: Venus Metals Corporation (VMC:AX)
Expected Higher Offer: Upside TBD (at A$0.195)
Quick Pitch: Priority Technology (PRTH)
Management Buyout: 14%+ Upside (at $5.41)
KNOT Offshore Partners (KNOP) — MLP Buyout — Upside TBD
Current Price: $9.8
Offer Price: $10 (expected to be increased)
Upside: TBD
Expected Timeline: 2-4 months
Golden Entertainment (GDEN) — Expected Higher Offer — 15%+ Upside
Current Price: $29.6
Target Price: $34+
Upside: 15%+
Expiration Date: H1 2026
Quick Pitch: AUB Group (AUB:AX)
Potential Buyout: 16% Upside (at A$38.73)
Taking It Private to Bring It Back to Life
The founder is leading a buyout to revive the struggling business.
TrueCar (TRUE) — Merger Arbitrage — 18% Upside
Current Price: $2.16
Target Price: $2.55
Upside: 18%
Expiration Date: Q4 2025 or early 2026
Guest Pitch: Generation Bio (GBIO)
Strategic review: 50% Upside (at $5.11)
Quick Pitch: Sotherly Hotels (SOHOO)
Merger Arbitrage: 12-14% Upside
Tile Shop Holdings (TTSH) — Reverse Stock Split — $720 Upside
Current Price: $6.24
Target Price: $6.60
Upside: $720 (for 1,999 shares) or 5.8%
Expiration Date: two months
Guest Pitch: Challenger Energy Group (CEG:L)
Merger Arbitrage (at 12.5p)
Quick Pitch: WonderFi Technologies (WNDR:TO)
Merger Arbitrage: 14% Upside (at C$0.315)
Share Class Arbitrage
After a successful first round in this share class arbitrage last year, it’s time for round two.
Lennar Corporation (LEN) — Split Off — $750 Upside
Current Price: $118.1
Offer Price: $125.6
Upside: 6.4% or $750 for odd-lot positions
Expiration date: November 7
Guest Pitch: Falcon Oil & Gas (FO:V)
Merger Arbitrage: 30% Upside (at C$0.20)
Quick Pitch: Yext (YEXT)
Merger arbitrage: Upside TBD (at $8.40)
CEO Floats Lowball Offer and Invites Competing Bids
The company is now in play, and downside is protected.
Quick Pitch: FONAR (FONR)
Merger arbitrage (at $15.22)
Quick Pitch: Chorus Aviation (CHR.TO)
Odd Lot Tender: C$45 upside (at C$22.55)
LakeShore Biopharma (LSBCF) — Merger Arbitrage — 90% Upside
Current Price: $0.45/share (edit: $0.70/share)
Offer Price: $0.86/share
Upside: 90% (edit: 25%)
Expected Timeline: TBD
Quick Pitch: STAAR Surgical (STAA)
Expected Higher Offer (at $27.2)
Quick Pitch: Forian (FORA)
Expected Higher Offer (at $2.1)
Quick Pitch: TaskUs (TASK)
Expected Improved Offer
Quick Pitch: scPharmaceuticals (SCPH)
CVR: 5:1 risk/reward
Quick Pitch: Apiam Animal Health (AHX:AX)
Merger Arbitrage (covered at A$0.795)
Quick Pitch: Plymouth Industrial REIT (PLYM)
Merger Arbitrage (at $21.30)
Guest Pitch: DallasNews (DALN)
Merger Arbitrage — 23% Upside (at $15)
Guest Pitch: Empresaria Group (EMR:L)
Merger Arbitrage: 48% Upside (at 42p)
Quick Pitch: Smart Share Global (EM)
Merger Arbitrage: 32% Upside (at $1.3)
Guest Pitch: ProAssurance (PRA)
Merger break: 35% potential return (at $23.8)
Quick Pitch: PMV Pharmaceuticals (PMVP)
Biopharma net-net — 40%+ Upside (at A$1.27)
Guest Pitch: Next Science (NXS.AX)
Large Capital Return (at A$0.14)
Quick Pitch: Banxa (BNXA:V)
Merger Arb: 23% Upside (at C$1.26)
Yorkville Acquisition (YORKU/MCGAU) — SPAC — Upside TBD
Current Price: $11.00
Target Price: TBD
Upside: potential multibagger
Expected Timeline: 1–2 years
Guest Pitch: Nanoco Group (NANO.L)
Potential Buyout: 50% upside (at 9.7p)
Guest Pitch: Real Estate Investors (RLE:L)
Liquidation: 35%-50% Upside (at £0.32/share)
Quick Pitch: Columbus Circle Capital Corp I (CCCM)
SPACs in the crypto space with a high chance of spiking upward
Quick Pitch: ProCap Acquisition (PCAPU)
SPACs in the crypto space with a high chance of spiking upward
Quick Pitch: M3-Brigade Acquisition V (MBAV)
SPACs in the crypto space with a high chance of spiking upward
Quick Pitch: Berto Acquisition (TACO)
SPACs in the crypto space with a high chance of spiking upward
Quick Pitch: Jupiter Mines (JMS:AX)
Potential Takeover: 60% Upside (at A$0.20/share)
Guest Pitch: Webjet Group (WJL:AX)
Potential Takeover — 30% Upside (at A$0.90/share)
Mayne Pharma (MYX:AX) — Merger Arb — 30%+ Upside
Current Price: A$4.90
Target Price: A$6.4+
Upside: 30%+
Expected Timeline: TBD
Three Lutnick’s SPACs — CEPO, CEPT and CAEP
Current Prices: $12.20 (CEPO), $11.50 (CEPT), $10.50 (CAEP)
Target Price: TBD
Upside: potential multibagger
Expected Timeline: 1–2 years
Quick Pitch: Naturgy Energy Group (NTGY:MC)
Odd-lot Tender Offer — €200+ Upside (€26/share)
Guest Pitch: Assura (AGR:L)
Expected higher offer — Upside TBD (at £0.495/share)
Asymmetric Bet with Multibagger Upside
Protected downside, a number of precedents worked out very well
Quick Pitch: Air Canada (AC:TO)
Tender Offer (Odd-Lot) — Free Option
Quick Pitch: Elevation Oncology (ELEV)
Potential Liquidation or Sale — 60% Upside (at $0.28/share)
Quick Pitch: Mayne Pharma (MYX:AX)
Merger Arbitrage (covered at A$6.48/share)
Guest Pitch: SmartPay Holdings (SMP:AX)
Potential Buyout (covered at A$0.92/share)
Wanda Hotel Development (0169:HK) – Asset Sale + Return of Capital – 40% Upside
Current Price: HK$0.46
Target Price: HK$0.65
Upside: 40%+
Expected Timeline: 6 months
Guest Pitch: Star Holdings (STHO)
Liquidation — 50%+ Upside (at $6.45/share)
Quick Pitch: Kronos Bio (KRON)
CVR play (at $0.714)
Quick Pitch: Theratechnologies (THTX)
Potential Takeover — 75%+ Upside (at $2.57/share)
Quick Pitch: Naturgy Energy Group (NTGY:MC)
Tender Offer With ‘Odd-Lot’ Type Priority — €500+ Upside
Quick Pitch: LENSAR (LNSR)
Buyout With a CVR: 23% Upside (at $13.63/share)
Quick Pitch: NIOX Group (NIOX:L)
Merger Arb — 9% upside (at 74.2p/share)
Guest Pitch: NZME Limited (NZM:AX)
SOTP value unlock — 35%+ upside (at A$1.1/share)
Guest Pitch: SAGA Pure (SAGA:OL)
Mandatory Bid/Privatization (at 1.31 NOK/share)
Lifeway Foods (LWAY) – Company Sale – 20%+ Upside
Current Price: $22.6
Target Price: $27+
Upside: 20%+
Expected Timeline: June 2025
Quick Pitch: Checkpoint Therapeutics (CKPT)
Free CVR (at $3.99)
Quick Pitch: OneConnect Financial Technology (OCFT)
Chinese Privatization — 22% Upside (at $6.5)
Quick Pitch: WEX Inc. (WEX)
Tender Offer +$1900 potential upside
Quick Pitch: Acelyrin (SLRN)
Merger Arbitrage (covered at $2.66)
Quick Pitch: Abrdn Diversified Income And Growth (ADIG:L)
Liquidation (covered at £0.47)
SpringWorks Therapeutics (SWTX) – Potential Buyout – 50% Upside
Current Price: $54.5
Target Price: $85
Upside: c. 50%
Expected Timeline: several weeks
Quick Pitch: Nathan’s Famous (NATH)
Potential sale: 45% Upside (at $102)
Sage Therapeutics (SAGE) – Expected Higher Offer – 30%+ Upside
Current Price: $7.16
Target Price: $9.5+
Upside: 30%+
Expected Timeline: 3 months
Guest Pitch: Nektar Therapeutics (NKTR)
Cheap shot at a blockbuster drug (at $0.73)
Quick Pitch: Paragon 28 (FNA)
Free CVR (at $13.01)
Quick Pitch: Allakos (ALLK)
Strategic review / NOL shell: Upside TBD
Guest Pitch: Copper Property CTL Trust (CPPTL)
Liquidation – 30%+ Upside (at $12.8/share)
Quick Pitch: Smart Share Global (EM)
Privatization: 20% Upside (at $1.00/share)
Quick Pitch: Revance Therapeutics (RVNC)
Merger Arb / Potential Bidding War: 11%+ Upside (at $3.27)
Quick Pitch: Destination XL Group (DXLG)
Merger Arb / Higher Offer: 15%-40% Upside (at $2.62)
Quick Pitch: Luna Innovations (LUNA)
Delisting / Potential sale – Multibagger Upside
Quick Pitch: D-Market Electronic Services & Trading (HEPS)
Mandatory buyout offer – 45% Upside
SPAR Group (SGRP) – Merger Break – 35%-50% Upside
Current Price: $2.17
Target Price: $1.00- $1.40
Upside: 35%-50%
Expected Timeline: 1-2 months
Kronos Bio (KRON) – Strategic Review of A Busted Biopharma – 48% Upside
Current Price: $0.94
Target Price: $1.39
Upside: 48%
Expected Timeline: Q1 2025
Quick Pitch: Equity Commonwealth (EQC)
Liquidation – 40%-60% Upside (on the stub)
Guest Pitch: Galaxy Gaming (GLXZ)
Merger Arb: 15% Upside
Quick Pitch: Essa Pharma (EPIX)
Strategic review of a busted biopharma – 30% Upside
Quick Pitch: HilleVax (HLVX)
Strategic review (busted biopharma) – 80% Upside
Territorial Bancorp (TBNK) – Merger Arbitrage – 23% Upside
Current Price: $10.17
Offer Price: $12.5
Upside: 23%
Expected Timeline: Oct 10
Quick Pitch: Northway Financial (NWYF)
Bancorp merger – 8-10% Upside
Guest Pitch: Gold Reserve (GDRZF)
Litigation: 130% Upside
VIZIO Holding (VZIO) – Short on Antitrust Concerns – 30% Upside
Current Price: $11.28
Target Price: $8
Potential gain on the short position: 30%
Expected Timeline: Q4 2024 / Q1 2025
Guest Pitch: WideOpenWest (WOW)
Expected higher offer – 50%+ Upside
Guest Pitch: Pact Group (PGH:AX)
Expected privatization – 30% Upside
Microstrategy (MSTR) – NAV Premium Arbitrage – 40% Upside
Current Price: $138
Target Price: $80
Upside: 40%
Expected Timeline: 1 year
OCI N.V. (OCI:AS) – Large Asset Sales & Capital Return – 25%+ Upside
Current Price: €26
Target Price: €32 (distribution of €14.5/share received in Oct’24)
Upside: 25%+
Expiration Date: H2 2024
Guest Pitch: Finch Therapeutics Group (FNCH)
Litigation: Multibagger Upside
Guest Pitch: musicMagpie (MMAG.L)
Potential Takeover – 200%+ Upside
Guest Pitch: Samsonite (1910:HK)
Uplisting to US: 90% Upside
Benson Hill (BHIL) – Buyout Arbitrage – 35% Upside
Current Price: $0.165 (or $5.77 post reverse-split)
Offer Price: $0.2236 (or $7.83 post reverse-split). *Offer increased to $8.6/share.
Upside: 35%
Expected Closing: H2 2024
Quick Pitch: Osino Resources (OSI:V)
Merger Arbitrage – 9% Upside
Quick Pitch: MIND Technology (MINDP)
Preferred Stock Conversion – 29% Upside
Ideas Elsewhere: WideOpenWest (WOW)
Expected higher offer – 90%+ upside
Quick Pitch: Matterport (MTTR)
Merger Arbitrage: 25% Upside
Guest Pitch: IMAX China (1970: HK)
Expected privatization: 30-50% upside
Quick Pitch: Mongolia Growth Group (MNGGF)
Large Discount To NAV / Liquidation – 30%+ Upside
Quick Pitch: Asensus Surgical (ASXC)
Merger Arbitrage – 40% Upside
Merger Arbs With Wide Spreads (Apr 2024)
With another quarter in the books, I am refreshing SSI review of all merger arbs with wide spreads.
Quick Pitch: M1 Kliniken (M12:DE)
Large Asset Sale
Guest Pitch: Sierra Rutile Holdings (SRX:AX)
Potential Bidding War – 45% Upside
Guest Pitch: Hipgnosis Songs Fund (SONG:L)
Potential Takeover – 40% Upside
Cummins (CMI) – Split Off – $1600 Upside
Current Price – $272
Offer Price – $291
Upside – 7.1% or $1600 for odd-lot positions
Expiration date – March 13 (tomorrow)
Marlowe (MRL:L) – Large Asset Sale & Capital Return – 50%+ Upside
Current Price: £5.06
Target Price: £7.7
Upside: 50%+
Expected Date: H2 2024
Liberty TripAdvisor (LTRPA) – Discount to NAV – 45% Upside
Current Discount: 30%
Target Discount: 0%
Potential Upside: 45%
Expected Timeline: Q2 2023
Quick Pitch: Guardion Health Sciences (GHSI)
Large Asset Sale & Potential Large Capital Return
Calumet Specialty Products (CLMT) – Discount to SOTP – 50%-200%+ Upside
Current Price: $16
Target Price: $24-$51
Upside: 50%-200%
Expected Timeline: 1-2 years
Liquidia (LQDA) – Drug Commercialization – 100%+ Upside
Current Price: $12.3
Target Price: $25+
Upside: 100%+
Estimated Timeline: 1 Year
Quick Pitch: Odyssey Marine Exploration (OMEX)
Upcoming Litigation Award
Quick Pitch: Avation (AVAP:L)
Activist Campaign / Company Sale
Quick Pitch: OreCorp (ORR:AX)
Merger Arbitrage/Potential Bidding War – 20%+ Upside
Guest Pitch: Telephone and Data Systems (TDS-PV)
Preferred Stock Re-Rating / Redemption, 40%+ Upside
Quick Pitch: Best Inc (BEST)
Chinese Privatization – 19% Upside
Quick Pitch: Docebo (DCBO)
Odd Lot Tender Offer – $1000 Upside
Quick Pitch: Talis Biomedical (TLIS)
Strategic Review – TBD Upside
Ascential (ASCL.L) – Large Asset Sale & Special Dividend – 30% Upside
Current Price: £2.7
Target Price: £3.6
Upside: 33%
Expiration Date: Q1 2024
Quick Pitch: Imperial Oil Limited (IMO.TO)
Odd Lot Tender Offer – C$350 Upside
MiX Telematics (MIXT) – Merger Arbitrage – 22% Upside
Current Price: $5.65
Target Price: $6.92
Upside: 22%
Expected Timeline: Q1 2024
Tidewater Midstream And Infrastructure (TWM.TO) – Large Asset Sale – Upside TBD
Current Price: C$1.03
Target Price: C$1.42
Upside: 40%
Expiration Date: Q4 2023
Ocean Wilson (OCN.L) – Large Asset Sale/Discount to NAV – 40% Upside
Current Price: £9.70
Target Price: £13.80
Upside: 40%
Expiration Date: end of 2023 / early 2024
Quick Pitch: Applied Molecular Transport (AMTI)
Merger Arbitrage – 40% Upside
Quick Pitch: Safeguard Scientifics (SFE)
Liquidation – 38%+ Upside
Quick Pitch: Direct Digital Holdings (DRCTW)
Warrants Cashout – 12% Upside
Kenvue (KVUE) – Price Recovery – 10%+ Upside
Current Price: $22.78
Target Price: $25-$26.5
Upside: 10%+
Expiration Date: 2 weeks
Quick Pitch: TriNet Group (TNET)
Odd-Lot Tender Offer – $270 Upside
Austal (ASB.AX) – Potential Takeover – 35% Upside
Current Price: A$2.22
Target Price: A$3.00
Upside: 35%
Expected Timeline: 2 months
Arix Bioscience (ARIX.L) – Potential Liquidation – 37% Upside
Current Price: £1.15
Expected Price: £1.58
Upside: 37%
Expected Timeline: TDB
Viking Energy (VKIN) – Merger Arbitrage – 35% Upside
Current Price: $0.63
Expected Price: $0.85
Upside: 35%
Expiration: around the 1st of Aug
Johnson & Johnson (JNJ) – Split Off – $2500 Upside
Current Price – $172.39
Offer Price – $185.32
Upside – 7.53% or $1280 for Odd Lot holders (or $2500 if exchange ratio is at the upper limit)
Expiration date – August 18, 2023
Neoleukin Therapeutics (NLTX) – Reverse Merger – Upside TBD
Current Price: $0.67
Expected Price: $1.00+
Upside: TBD
Expected timeline: Q4 2023
GAN Limited (GAN) – Company Sale – Upside TBD
Current Price: $1.32
Expected Price: $3.00+
Upside: TBD
Expected timeline: 2-3 months
Talaris Therapeutics (TALS) – Potential Liquidation – 25%+ Upside
Current price: $2.4
Liquidation value: $3.05-$3.30 per share
Upside: 25%-40%
Expiration date: 2023
Companhia Brasileira de Distribuicao (CBD) – Spin-Off – 20%+ Upside
Current Price: $3.03
Target Price: $3.67
Upside: 20%+
Expiration Date: Q2 2023
Quick Pitch: Delek US (DK)
Unlock of SOTP Value: 100% Upside
Enzo Biochem (ENZ) – Divesture and SOTP Discount – 50%+ Upside
Current Price: $2.1
Target Price: $3.25
Upside: 50%+
Expiration Date: Q2’23
TCR2 Therapeutics (TCRR) – Merger Arbitrage – 14% Upside
Current Price: $1.48
Offer Price: $1.69
Upside: 14%
Expected Closing: Q2 2023
Metacrine (MTCR) – Liquidation – 20% Upside
Current Price: $0.54
Target Price: $0.65
Upside: 20%
Expiration Date: Q2’23
GasLog Partners (GLOP) – Expected Higher Bid – 40% Upside
Current Price: $8.75
Target Price: $12.00
Upside: 40%
Expiration Date: end of 2023
Vertical Capital Income Fund (VCIF) – Manager/Strategy Change – Upside 20%+
Current Price: $9.6
Total Price: TBD
Upside: 20%+
Expiration Date: end of 2023
2022 Review – Wins and Mistakes
Happy New Year everyone! With the holiday season already behind us, the time has come again to look back and reflect on performance during the last year.
Blucora (BCOR) – Asset Sale/Large Capital Return – Upside TBD
Current Price: $24.05
Target Price: TBD
Upside: TBD
Expiration Date: H1 2023
First Eagle Alternative Capital BDC (FCRD) – Merger Arbitrage – 14% Upside
Current Price: $4.21
Offer Price: $4.80
Upside: 14%
Expected Closing: early Q1 2023
Cornerstone Capital Resources (CGP.V) – Merger Arb and Company Sale – Upside TBD
Current Price: C$3.30
Offer Price: C$3.66
Current Spread: 11%
Expiration Date: Q4 2022
111 (YI) – Management Privatization – 30% Upside
Current Price: $2.77
Offer Price: $3.61
Upside: 30%
Expected Closing Date: TBD
Metacrine (MTCR) – Merger Arbitrage – 22% Upside
Current Price: $0.48
Offer Price: $0.58
Upside: 22%
Expected Closing: Late 2022
Nanoco Group (NANO.L) – Patent Litigation – Multibagger Upside
Current Price: £0.52
Target Price: £1.25 – £3.00
Upside: 2x – 6x
Expiration Date: TBD
Hollysys Automation Technologies (HOLI) – Expected Management Privatization – 53% Upside
Current Price: $19.00
Offer Price: $29.00
Upside: 53%
Expiration Date: TBD
Liberty TripAdvisor Holdings (LTRPA) – Capital Structure Arbitrage – 100% Upside
Current Discount: 50%
Target Discount: 0%
Upside: 100% (depending on hedging ratio used)
Expiration Date: TBD
3M Company (MMM) – Split-off – $1000 Upside
Current Price: $148.12
Offer Price: $158.49
Upside: 7% or $1000 (for odd-lots)
Expiration Date: August 31
ThinkSmart (TSL.L) – Merger Arbitrage – 12% Upside
Current Price: £0.35
Offer Price: £0.39
Upside: 12%
Expected Closing Date: Nov’22
Sisecam Resources (SIRE) – Expected Higher Bid – 40% Upside
Current Price: $18.14
Offer Price: $17.90 (expected to be increased to $26)
Upside: expected +40%
Expiration Date: TBD (probably 6+ months)
Tyme Technologies (TYME) – Merger Arbitrage – 33% Upside
Current Price: $0.265
Offer Price: $0.353 (in stock)
Upside: 33%
Expected Closing Date: H2 2022
24 Merger Arbs With Wide Spreads
Merger arb spreads are wide and there is a high number of opportunities now present in the straight-forward merger arbitrage space. Some of these have already been highlighted or posted on SSI. But to get a better picture, we have reviewed all US M&A deals with spreads of 10%+ (or close to it).
PBF Logistics (PBFX) – Expected Takeover – 15%-20% Upside
Current Price: $15.5
Expected Offer Price: $18 – $19
Upside: 15% – 20%
Expiration Date: TBD
Metromile (MILE) – Merger Arbitrage – 13% Upside
Current Price: $0.91
Offer Price: $1.03
Upside: 13%
Expected Closing Date: Early Q3 2022
Shell Midstream Partners (SHLX) – Expected Higher Offer – Upside TBD
Current Price: $13.80
Offer Price: $12.89 (likely to be increased)
Upside: exp. up to 10%
Timeline: 2-3 months
Seritage Growth Properties (SRG) – Strategic Alternatives/Asset Sales – 100%+ Upside
Current Price: $8.08
Target Price: $17.06
Upside: 100%+
Expiration Date: TBD
Genesis Metals (GIS.V) – Merger Arbitrage – 26% Upside
Current Price: C$0.145
Offer Price: C$0.18
Upside: 26%
Expected Closing Date: July 2022
BlueCity (BLCT) – Going Private – 20%+ Upside
Current Price: $1.28
Offer Price: $1.55 (adj. by the ADS fee)
Upside: 20%+
Expected Closing Date: H2 2022
Link Administration (LNK.AX) – Merger Arbitrage – 26% Upside
Current Price: A$4.47
Offer Price: A$5.65
Upside: 26%
Expected Closing: Aug’22
Bally’s (BALY) – Expected Tender Offer – Upside TBD
Current Price: $35.38
Offer Price: $38.00 (increase expected)
Upside: 6%+
Expiration Date: TBD
Marrone Bio Innovations (MBII) – Merger Arbitrage – 16% Upside
Current Price: $0.99
Offer Price: $1.15
Upside: 16%
Expiration Date: Q3 2022
Large-cap M&A basket
Given the recent widening of the arbitrage spreads we have reassessed all of the U.S. listed large-cap arbitrages with 10%+ spreads and selected 6 of those situations for our large-cap M&A basket.
PharmChem (PCHM) – Turnaround – Upside 100%+
Current Price: $3.68
Target Price: $7+
Upside: 100%+
Expiration Date: TBD
Atento (ATTO) – Rumored Merger – Upside TBD
Current Price: $29.6
Target Price: TBD
Upside: 30%
Expiration Date: Q1-Q2 2022
StarTek (SRT) – Merger Arbitrage – 30% Upside
Current Price: $4.13
Offer Price: $5.40
Upside: 31%
Expiration Date: mid-2022
Opera (OPRA) – Share Buybacks/Hidden Assets – Upside TBD
Current Price: $5.72
Target Price: TBD
Upside: TBD
Expiration Date: TBD
Pan American Silver (PAASF) – CVR – 100% Upside
Current Price: $0.82
Offer Price: $1.65 (updated, see comment below)
Upside: 100%
Expiration Date: Q1 2029
Advanced Emissions Solutions (ADES) – Large Capital Return/Company Sale – Upside TBD
Current Price: $6.2
Target Price: TBD
Upside: TBD
Expiration Date: Mid-2022
Liberty TripAdvisor Holdings (LTRPA) – Capital Structure Arbitrage – Upside 10%-20%+
Current Premium: 20% (LTRPA at $2.01 and TRIP at $24.2)
Target Premium: -15%
Upside: 20%+ (depending on hedging ratio used)
Expiration Date: TBD
Cornerstone Building Brands (CNR) – Merger Arbitrage – 13% Upside
Current Price: $21.84
Offer Price: $24.65
Upside: 13%
Expected Closing Date: TBD
Far Limited (FAR.AX) – Liquidation/Activism Pressure – 50%+ Upside
Current Price: A$0.68 (A$0.4 dividend already distributed)
Target Price: A$1.07+
Upside: 50%+
Expected Expiration: Q2 2022
Taiga Building Products (TBL.TO) – Expected Large Dividend – Upside TBD
Current Price: C$2.82
Target Price: TBD
Upside: TBD
Expiration Date: February 2022
Western Areas (WSA.AX) – Potential Bidding War – Upside TBD
Current Price: A$3.46
Offer Price: A$3.36 (outbid expected)
Upside: TBD
Expiration Date: April 2022
Kohl’s (KSS) – Activist Pressure/Potential Bidding War – 25%+ Upside
Current Price: $60.16
Offer Price: $75+
Upside: 25%+
Expiration Date: Q1-Q2 2022
Reitmans Canada (RET-A.V) – Post-Bankruptcy & Uplisting – Upside TBD
Current Price: C$1.99
Target Price: TBD
Upside: TBD
Expiration Date: April 2022
Blueknight Energy Partners (BKEP) – Expected Offer Increase – 60% Upside
Current Price: $3.25
Offer Price: TBD (current at $3.32)
Upside: 60%+
Expiration Date: March 2022
Twin Vee Powercats (VEEE) – Spin-Off – 50%+ Upside
Current Price: $3.92
Target Price: $6.00+
Upside: 50%+
Expiration Date: Q2-Q3 2022